Eyecarrot Innovations Corp is pleased to announce its President and Co-founder Adam Cegielski will present at the annual LD Micro Invitational.
TORONTO, June 4, 2018 /PRNewswire/ -- Eyecarrot Innovations Corp (“Eyecarrot” or the “Company”) (TSX-V: EYC) (OTCQB: EYCCF) is pleased to announce its President and Co-founder Adam Cegielski will present at the annual LD Micro Invitational on Tuesday, June 5th, 2018 at 3:30 PM PST / 6:30 PM EST. Cegielski will discuss Eyecarrot’s technology platform (Binovi), its strategy to become the go-to Vision Therapy app on a global scale, and its products, including recently reengineered and launched Binovi Touch Saccadic Fixator. Management will be available on June 4 for one-on-one meetings with investors who are registered to attend the conference.
The conference will be held at the Luxe Sunset Bel Air Hotel, will feature 230 companies in the small-cap / micro-cap space, and will be attended by over 1,000 individuals.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. The firm hosts several influential conferences annually (Invitational, Summit, and Main Event). In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and micro-cap universe.
See LD Micro’s Webiste; https://www.ldmicro.com/events
About Eyecarrot
Eyecarrot’s BinoviTM platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient’s experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.
On behalf of the Board of Directors Adam Cegielski President | CEO
Forward looking information
Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at http://www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
T: (416)-943-6271-l 1-855 416 7158
info@eyecarrot.com
SOURCE Eyecarrot Innovations Corp
